Baker McKenzie Advises QingSong Health on its Global Offering and Hong Kong Listing

Baker McKenzie acted as the Hong Kong and US legal adviser to QingSong Health Corporation ("QingSong Health") on its successful global offering and listing on the Main Board of the Hong Kong Stock Exchange. The offering is expected to raise approximately HKD 513.4 million in net proceeds (or approximately HKD 599.6 million if the over-allotment option is fully exercised). The company's H shares (stock code: 2661) commence trading today.

QingSong Health is a leading tech-enabled platform providing integrated healthcare- and insurance-related services in China, ranking seventh in China's digital healthcare services market in terms of revenue. Proceeds from the offering will be used to enhance its market profile, strengthen business partnerships, expand market reach, invest in medical studies and real-world research, advance technology and AI capabilities, as well as for working capital and general corporate purposes.

The deal team is led by Dan Ouyang, partner and co-chair of Baker McKenzie's Asia Pacific and China Capital Markets practices, and Winfield Lau (Partner) from Baker McKenzie, alongside Ronnie Li and Zhenzhen Bao from FenXun's International Capital Markets Practice.* The core team members included Vicky Zheng, Giselle Ma,Layla Du, Grace Zhang, Kody Yan and Charlton Lau.

Commenting on the deal, Dan Ouyang said: "We are thrilled to have supported QingSong Health on its successful listing, which provides the company with new funding to drive future growth. This transaction highlights our strength and proven track record in equity capital markets. We look forward to continuing to leverage our robust expertise to assist clients with future transactions as Hong Kong's capital market activities gain momentum."

China International Capital Corporation Hong Kong Securities Limited and China Merchants Securities (HK) Co., Limited acted as joint sponsors and overall coordinators. They also acted as joint global coordinators, joint bookrunners and joint lead managers, along with Futu Securities International (Hong Kong) Limited. SPDB International Capital Limited acted as joint bookrunner and joint lead manager.

With more than 2,700 deal practitioners in more than 40 jurisdictions, Baker McKenzie is a transactional powerhouse. The Firm excels in complex cross-border transactions - over 65% of our deals are multijurisdictional. The teams are a hybrid of "local" and "global," combining money-market sophistication with local excellence. Over the past three years, Baker McKenzie has helped clients raise capital across more than 40 stock exchanges worldwide. The Firm has been ranked for capital markets in more jurisdictions than any other by Chambers.

*Baker McKenzie established a joint operation office with FenXun in China as Baker McKenzie FenXun, approved by the Shanghai Justice Bureau in 2015.